FDA.reportPublic FDA data

bempedoic acid 180 MG Oral Tablet [Nexletol]

RxCUI
2282414
RxNorm name
bempedoic acid 180 MG Oral Tablet [Nexletol]
Display name
bempedoic acid 180 MG Oral Tablet [Nexletol]
Full name
bempedoic acid 180 MG Oral Tablet [Nexletol]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:07

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NexletolBEMPEDOIC ACIDEsperion Therapeutics, Inc.88d06d89-a3da-40b4-b273-8f4f7d56c4c92026-06-25Warnings, Adverse reactionsExact identifier
rxcui: 2282414

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
88d06d89-a3da-40b4-b273-8f4f7d56c4c9NEXLETOL 180 MG Oral Tablet [PSN] · bempedoic acid 180 MG Oral Tablet [Nexletol] [SBD] · Nexletol 180 MG Oral Tablet [SY]319These highlights do not include all the information needed to use NEXLETOL ® safely and effectively. See full prescribing information for NEXLETOL. NEXLETOL (bempedoic acid) tablets, for oral use Initial U.S. Approval: 202020260115